CD133-Guided RNA Nanoparticle Delivery of FTO siRNA Impairs Leukemia Resistance to Tyrosine Kinase Inhibitor Therapy

RNA Nanoparticles Harboring Radioisotopes or Other Imaging Molecules for Spontaneous Tumor Targeting for Early Cancer Diagnosis

Targeting EGFR self-assembling RNA nanoparticles co-delivering paclitaxel and miRNA21 inhibitors for the treatment of head and neck tumors

Leveraging Immunological Properties of NucleicAcid Nanoparticles to Improve Cancer Therapy

Nucleic-Acid Based Approaches for Detection of microRNA

The Reduction of Traumatic Spinal Cord Secondary Injury by Anti-RhoA siRNA Functionalized Nucleic Acid Nanoparticles (NANPs)

Applications of Surface Plasmon Resonance for Advanced Studies Involving Nucleic Acids

Targeted Delivery of Potent Chemical Drugs and RNAi to Drug-Resistant Breast Cancer Using RNA-Nanotechnology and RNA-Ligand Displaying Extracellular vesicles

pH-responsive bond as a linker for the release of chemical drugs from RNA–drug complexes in endosome or lysosome

Conversion of Chemical Drugs into Targeting Ligands on RNA Nanoparticles and Assessing Payload Stoichiometry for Optimal Biodistribution in Cancer Treatment